Abstract:Ultrasmall ferrite nanoparticles (UFNPs) have emerged as powerful magnetic resonance imaging (MRI) T1 nanoprobe for noninvasive visualization of biological events. However, the structure–relaxivity relationship and regulatory mechanism of UFNPs remain elusive. Herein, we developed chemically engineered 3.8 nm ZnxFe3–xO4@ZnxMnyFe3–x–yO4 (denoted as ZnxxMnyF) nanoparticles with precise dopants control in both crystalline core and disordered shell as a model system to assess the impact of dopants on the relaxometric properties of UFNPs. It is determined that the core–shell dopant architecture allows the optimal tuning of r1 relaxivity for Zn0.40.4Mn0.2F up to 20.22 mM–1 s–1, which is 5.2-fold and 6.5-fold larger than that of the original UFNPs and the clinically used Gd-DTPA. Moreover, the high-performing UFNPs nanoprobe, when conjugated with a targeting moiety AMD3100, enables the in vivo MRI detection of small lung metastasis with greatly enhanced sensitivity. Our results pave the way toward the chemical design of ultrasensitive T1 nanoprobe for advanced molecular imaging.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.nanolett.0c04574?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.nanolett.0c04574</a>.Experimental section, theoretical simulations, simulated relaxivities, detailed reaction parameters, EDS mappings, EDX spectra, TEM images, diameter histograms, size, magnetization, and MR relaxivities, characterization of water-soluble UFNPs/TEM images, XANES spectra, hysteresis loops, concentration plots, XRD pattens, comparison of the relaxivities reported for ultrasmall ferrite nanoparticles, viabilities of the cells, in vivo toxicology assessment, blood pharmacokinetics, and T1-weighted MR images (<a class="ext-link" href="/doi/suppl/10.1021/acs.nanolett.0c04574/suppl_file/nl0c04574_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Renal-clearable Zwitterionic Conjugated Hollow Ultrasmall Fe3O4 Nanoparticles for T1-weighted MR Imaging in Vivo.

Synthesis of Ultrasmall Fe3O4 Nanoparticles As T1–T2 Dual-Modal Magnetic Resonance Imaging Contrast Agents in Rabbit Hepatic Tumors

Quasi-amorphous and Hierarchical Fe2O3 Supraparticles: Active T1-Weighted Magnetic Resonance Imaging in Vivo and Renal Clearance

Fe3O4 Nanoparticles Functionalized with Polymer Ligand for T-1-Weighted MRI in Vitro and in Vivo

Ultracompact Iron Oxide Nanoparticles with a Monolayer Coating of Succinylated Heparin: A New Class of Renal-Clearable and Nontoxic T1 Agents for High-Field MRI.

Synthesis of well-dispersed aqueous-phase magnetite nanoparticles and their metabolism as an MRI contrast agent for the reticuloendothelial system

Redox-Sensitive Clustered Ultrasmall Iron Oxide Nanoparticles for Switchable T2/T1-Weighted Magnetic Resonance Imaging Applications

Highly Sensitive Early Diagnosis of Kidney Damage Using Renal Clearable Zwitterion‐Coated Ferrite Nanoprobe via Magnetic Resonance Imaging In Vivo

Synthesis of Au-Fe3O4 heterostructured nanoparticles for in vivo computed tomography and magnetic resonance dual model imaging.

2, 3-Dimercaptosuccinic Acid-Modified Iron Oxide Clusters for Magnetic Resonance Imaging

Structure-Relaxivity Mechanism of an Ultrasmall Ferrite Nanoparticle T1 MR Contrast Agent: the Impact of Dopants Controlled Crystalline Core and Surface Disordered Shell.

Synthesis of sub-100 nm biocompatible superparamagnetic Fe3O4 colloidal nanocrystal clusters as contrast agents for magnetic resonance imaging

Developing Fe3O4 nanoparticles into an efficient multimodality imaging and therapeutic probe.

Preparation and Imaging Study of Tumor-Targeting Mri Contrast Agent Based on Fe3o4 Nanoparticles

In Situ One-Pot Synthesis of Fe 2 O 3 @BSA Core-Shell Nanoparticles as Enhanced T 1 -Weighted Magnetic Resonance Imagine Contrast Agents

Active-target T1-weighted MR Imaging of Tiny Hepatic Tumor via RGD Modified Ultra-small Fe3O4 Nanoprobes

Albumin-constrained large-scale synthesis of renal clearable ferrous sulfide quantum dots for T1-Weighted MR imaging and phototheranostics of tumors

Synthesis and characterization of stable water-soluble Fe3O4 nanoparticles

Fe5C2 nanoparticles with high MRI contrast enhancement for tumor imaging.

Structure–Relaxivity Mechanism of an Ultrasmall Ferrite Nanoparticle T 1 MR Contrast Agent: The Impact of Dopants Controlled Crystalline Core and Surface Disordered Shell

Targeted Dual-Contrast T1- and T2-weighted Magnetic Resonance Imaging of Tumors Using Multifunctional Gadolinium-Labeled Superparamagnetic Iron Oxide Nanoparticles